These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 20600885)
1. Colonic delivery of carboxyfluorescein by pH-sensitive microspheres in experimental colitis. Kietzmann D; Moulari B; Béduneau A; Pellequer Y; Lamprecht A Eur J Pharm Biopharm; 2010 Oct; 76(2):290-5. PubMed ID: 20600885 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis. Oosegi T; Onishi H; Machida Y Int J Pharm; 2008 Feb; 348(1-2):80-8. PubMed ID: 17714892 [TBL] [Abstract][Full Text] [Related]
3. Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules. Smrdel P; Cerne M; Bogataj M; Urleb U; Mrhar A J Microencapsul; 2010; 27(7):572-82. PubMed ID: 20690794 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis. Onishi H; Oosegi T; Machida Y Int J Pharm; 2008 Jun; 358(1-2):296-302. PubMed ID: 18394832 [TBL] [Abstract][Full Text] [Related]
5. pH-sensitive microsphere delivery increases oral bioavailability of calcitonin. Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y J Control Release; 2004 Jul; 98(1):1-9. PubMed ID: 15245884 [TBL] [Abstract][Full Text] [Related]
6. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Nishi T; Debreceni A; Itoh T; Kawanami C; Iwano M; Ikada Y; Chiba T J Pharmacol Exp Ther; 2001 Jun; 297(3):1122-8. PubMed ID: 11356937 [TBL] [Abstract][Full Text] [Related]
7. A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles. Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y J Control Release; 2005 May; 104(2):337-46. PubMed ID: 15907584 [TBL] [Abstract][Full Text] [Related]
9. Bioefficacy of budesonide loaded crosslinked polyelectrolyte microparticles in rat model of induced colitis. Crcarevska MS; Dodov MG; Petrusevska G; Gjorgoski I; Goracinova K J Drug Target; 2009 Dec; 17(10):788-802. PubMed ID: 19938950 [TBL] [Abstract][Full Text] [Related]
10. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. Lamprecht A; Ubrich N; Yamamoto H; Schäfer U; Takeuchi H; Maincent P; Kawashima Y; Lehr CM J Pharmacol Exp Ther; 2001 Nov; 299(2):775-81. PubMed ID: 11602694 [TBL] [Abstract][Full Text] [Related]
11. Nanoparticles in inflammatory bowel disease: particle targeting versus pH-sensitive delivery. Meissner Y; Pellequer Y; Lamprecht A Int J Pharm; 2006 Jun; 316(1-2):138-43. PubMed ID: 16675176 [TBL] [Abstract][Full Text] [Related]
12. Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats. Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y J Pharmacol Exp Ther; 2005 Oct; 315(1):196-202. PubMed ID: 15980057 [TBL] [Abstract][Full Text] [Related]
13. Colon-Targeted Therapy of Tacrolimus (FK506) in the Treatment of Experimentally Induced Colitis. Ali AS; Altayari AA; Khan LM; Alharthi SE; Ahmed OA; El-Shitany NA; Ali SS; Saadah OI Pharmacology; 2020; 105(9-10):541-549. PubMed ID: 31940656 [TBL] [Abstract][Full Text] [Related]
14. Design of pH-sensitive microspheres for the colonic delivery of the immunosuppressive drug tacrolimus. Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y Eur J Pharm Biopharm; 2004 Jul; 58(1):37-43. PubMed ID: 15207535 [TBL] [Abstract][Full Text] [Related]
15. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy. Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440 [TBL] [Abstract][Full Text] [Related]
16. Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoate. Anande NM; Jain SK; Jain NK Int J Pharm; 2008 Jul; 359(1-2):182-9. PubMed ID: 18486369 [TBL] [Abstract][Full Text] [Related]
17. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease. Yadav VR; Suresh S; Devi K; Yadav S J Pharm Pharmacol; 2009 Mar; 61(3):311-21. PubMed ID: 19222903 [TBL] [Abstract][Full Text] [Related]
18. Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis. Bautzová T; Rabišková M; Béduneau A; Pellequer Y; Lamprecht A Eur J Pharm Biopharm; 2012 Jun; 81(2):379-85. PubMed ID: 22386911 [TBL] [Abstract][Full Text] [Related]
19. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis. Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681 [TBL] [Abstract][Full Text] [Related]
20. [Studies on the influence of Candida fungal colonization on the healing process of inflammatory lesions in the colon in rat animal model]. Zwolińska-Wcisło M; Brzozowski T; Budak A; Sliwowski Z; Drozdowicz D; Kwiecień S; Trojanowska D; Rudnicka-Sosin L; Mach T; Konturek SJ; Pawlik WW; Targosz A Przegl Lek; 2007; 64(3):124-9. PubMed ID: 17941462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]